2H-1-Benzopyran-6-ol, 3,4-dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-, 6-acetate, (2R)-rel-, 98%, 98%

cas: 52225-20-4 — see every product listed under this CAS number, including other names

2H-1-Benzopyran-6-ol, 3,4-dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-, 6-acetate, (2R)-rel-, 98%, 98% (CAS 52225-20-4) is a chemical reagent available from Chemat. Available pack sizes: 25g, 100g, 500g. Offered by: Chemat.

• 2D
• 3D

DL-alpha-Tocopherol acetate is a tocol.

Source: ChEBI

Identity

Molecular formula	C31H52O3
Molecular weight	472.7 g/mol
IUPAC name	[2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-3,4-dihydrochromen-6-yl] acetate
InChIKey	ZAKOWWREFLAJOT-UHFFFAOYSA-N
SMILES	CC1=C(C(=C(C2=C1OC(CC2)(C)CCCC(C)CCCC(C)CCCC(C)C)C)OC(=O)C)C

Computed by PubChem (NCBI)

Synonyms: DL-alpha-Tocopherol acetate, all-rac-alpha-Tocopheryl acetate, (+-)-alpha-Tocopherol acetate, Alpha-tocopherol acetate, dl-, Tocopheryl Acetate, dl-Alpha, Alpha-tocopheryl acetate, dl-, Vitamin E acetate dl-, Tocopheryl acetate,dl-alpha, d,l-alpha-Tocopherol Acetate, Tocopheryl acetate

Related forms of this compound

[(2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl] acetate C₃₁H₅₂O₃

[2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-3,4-dihydrochromen-6-yl] acetate C₃₁H₅₂O₃

[(2R)-2,8-dimethyl-5,7-bis(trideuteriomethyl)-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl] acetate C₃₁H₅₂O₃

[(2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl] 2,2,2-trideuterioacetate C₃₁H₅₂O₃

Isomers (same molecular formula)

[4-methoxy-2,6-dimethyl-3-(3,7,11,15-tetramethylhexadec-2-enyl)phenyl] acetate C₃₁H₅₂O₃

[(2R,3R)-2,3,4,6,7-pentamethyl-2-(4,8,12-trimethyltridecyl)-3H-1-benzofuran-5-yl] acetate C₃₁H₅₂O₃

[(5S,8R,9S,10S,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl] dodecanoate C₃₁H₅₂O₃

[(3S,8S,9S,10R,13R,14S)-17-[(2R,4R,5S)-5-ethyl-4-hydroxy-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate C₃₁H₅₂O₃

[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] propan-2-yl carbonate C₃₁H₅₂O₃

(5R,8R,9R,10R,13R,14R,17S)-17-[(2S,6S)-6-methoxy-2,5,5-trimethyloxan-2-yl]-4,4,8,10,14-pentamethyl-1,2,5,6,7,9,11,12,13,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one C₃₁H₅₂O₃

(3S,4S,4aR,6aR,6bS,8aR,9R,14aR,14bR)-4-(hydroxymethyl)-9-methoxy-4,6a,6b,8a,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,13,14,14a-tetradecahydropicen-3-ol C₃₁H₅₂O₃

(3S,7S,8R,9S,10S,13R,14S,17R)-17-[(E,2R)-6-hydroxy-6-methylhept-4-en-2-yl]-7-methoxy-4,4,9,13,14-pentamethyl-2,3,7,8,10,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol C₃₁H₅₂O₃